Home LiteratureArticle Details
PMID: 9233726 Published · ppublish English Comment Editorial Review

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

Critical care medicine ·Vol. 25 ·No. 7 ·1997-07-00 ·Pages 1095-100

Zeni F, Freeman B, Natanson C

Abstract

暂无摘要

MeSH Terms
Anti-Inflammatory Agents/therapeutic use Clinical Trials as Topic Glucocorticoids/therapeutic use Humans Interleukin 1 Receptor Antagonist Protein Receptors, Immunologic/antagonists & inhibitors Receptors, Interleukin-1/antagonists & inhibitors Recombinant Proteins Sepsis/drug therapy Shock, Septic/drug therapy Sialoglycoproteins/therapeutic use
Chemicals
Anti-Inflammatory Agents Glucocorticoids IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Receptors, Immunologic Receptors, Interleukin-1 Recombinant Proteins Sialoglycoproteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zeni F
Freeman B
Natanson C
Article Info
Journal
Critical care medicine
Abbr.
Crit Care Med
ISSN
0090-3493
DOI
10.1097/00003246-199707000-00001
Published
1997-07-00
Pages
1095-100
Language
English
Region
United States
NLM ID
0355501
Subset
IM
Corrections
CommentOn
PMID: 9233735
External Links
PubMed source DOI: 10.1097/00003246-199707000-00001 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2